Balance Sheet - Monte Rosa Therapeutics, Inc. (GLUE)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 377.10 | 372.15 | 232.41 | 262.83 | 346.07 | 41.70 | 6.00 |
| Accounts receivable, net | 4.60 | 0.17 | 0.51 | 7.66 | 0.08 | 0.05 | |
| Inventories | 0.96 | ||||||
| Other current assets | 11.48 | 5.12 | 3.29 | 5.40 | 2.60 | 1.89 | 3.76 |
| Total current assets | 393.19 | 377.44 | 236.21 | 275.89 | 348.67 | 43.59 | 9.76 |
| Total non-current assets | 55.47 | 61.29 | 67.54 | 66.50 | 17.66 | 5.79 | 1.34 |
| Total assets | 448.66 | 438.73 | 303.76 | 342.39 | 366.33 | 49.38 | 11.09 |
| Total current liabilities | 64.21 | 156.95 | 46.59 | 25.57 | 16.64 | 29.28 | 4.29 |
| Total non-current liabilities | 151.39 | 58.85 | 77.91 | 45.41 | 2.18 | 68.83 | 18.95 |
| Total liabilities | 215.60 | 215.80 | 124.51 | 70.98 | 18.81 | 98.11 | 23.24 |
| Total stockholders' equity | 233.06 | 222.94 | 179.25 | 271.41 | 347.52 | -48.73 | -12.15 |
| Common shares outstanding | 83 | 74 | 51 | 47 | 47 | 44 | 44 |
Show Quarterly Balance Sheet
Balance Sheet - Monte Rosa Therapeutics, Inc. (GLUE)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 666.22 | 377.10 | 391.26 | 290.59 | 326.07 | 372.15 | 242.19 | 262.21 | 192.89 | 232.41 | 178.48 | 203.07 | 231.73 | 262.83 | 272.15 | 294.15 | 317.16 | 346.07 | 367.03 | 357.06 | 168.44 | 41.70 | 0.00 | 0.00 | 6.00 |
| Accounts receivable, net | 4.61 | 4.60 | 4.97 | 2.37 | 1.41 | 0.17 | 0.60 | 9.84 | 0.60 | 0.51 | 0.29 | 1.15 | 2.17 | 7.66 | 17.56 | 0.38 | 0.04 | 0.08 | |||||||
| Inventories | 0.00 | 0.96 | 0.96 | ||||||||||||||||||||||
| Other current assets | 6.72 | 11.48 | 5.59 | 6.50 | 4.80 | 5.12 | 8.43 | 5.85 | 5.54 | 3.29 | 4.14 | 3.88 | 6.65 | 5.40 | 5.53 | 2.90 | 3.20 | 2.60 | 3.49 | 1.23 | 3.27 | 1.89 | |||
| Total current assets | 677.55 | 393.19 | 401.82 | 299.47 | 332.28 | 377.44 | 251.21 | 277.90 | 199.04 | 236.21 | 182.91 | 208.10 | 240.56 | 275.89 | 295.24 | 297.05 | 320.37 | 348.67 | 370.52 | 358.29 | 171.71 | 43.59 | 6.00 | ||
| Total non-current assets | 58.88 | 55.47 | 58.02 | 60.12 | 60.92 | 61.29 | 63.87 | 66.22 | 67.71 | 67.54 | 69.19 | 70.51 | 68.47 | 66.50 | 62.37 | 68.01 | 25.64 | 17.66 | 13.53 | 10.65 | 8.90 | 5.79 | -6.00 | ||
| Total assets | 736.43 | 448.66 | 459.84 | 359.59 | 393.20 | 438.73 | 315.08 | 344.11 | 266.75 | 303.76 | 252.10 | 278.62 | 309.03 | 342.39 | 357.60 | 365.06 | 346.01 | 366.33 | 384.05 | 368.94 | 180.60 | 49.38 | |||
| Total current liabilities | 71.04 | 64.21 | 61.44 | 41.85 | 59.22 | 156.95 | 41.64 | 42.35 | 41.29 | 46.59 | 22.61 | 19.09 | 20.52 | 25.57 | 21.79 | 14.77 | 12.49 | 16.64 | 12.74 | 10.79 | 9.09 | 29.28 | |||
| Total non-current liabilities | 143.48 | 151.39 | 152.56 | 49.65 | 58.82 | 58.85 | 67.98 | 77.10 | 72.93 | 77.91 | 44.97 | 45.87 | 44.79 | 45.41 | 44.72 | 48.23 | 7.64 | 2.18 | 2.00 | 1.47 | 232.13 | 68.83 | |||
| Total liabilities | 214.51 | 215.60 | 214.00 | 91.51 | 118.04 | 215.80 | 109.62 | 119.44 | 114.23 | 124.51 | 67.58 | 64.96 | 65.30 | 70.98 | 66.51 | 63.01 | 20.13 | 18.81 | 14.74 | 12.26 | 241.22 | 98.11 | |||
| Total stockholders' equity | 521.92 | 233.06 | 245.84 | 268.08 | 275.16 | 222.94 | 205.46 | 224.67 | 152.52 | 179.25 | 184.52 | 213.65 | 243.73 | 271.41 | 291.09 | 302.05 | 325.88 | 347.52 | 369.31 | 356.68 | -60.62 | -48.73 | 6.80 | ||
| Common shares outstanding | 66 | 66 | 82 | 82 | 83 | 61 | 82 | 71 | 60 | 57 | 50 | 49 | 49 | 49 | 47 | 47 | 47 | 46 | 46 | 46 | 43 | 22 | 22 | 22 | 22 |